Market Place
Market Place
Post Enquiry
Zydus Pharma`s Generics Paliperidone Receives Approval in US
08 Oct 2024 //
FDA
Saptalis`s Generics Glycopyrrolate Receives Approval in US
07 Oct 2024 //
FDA
Novartis`s Biologic Cosentyx (Secukinumab) Receives Approval in US
04 Oct 2024 //
FDA
Bristol Myers`s Biologic Opdivo (Nivolumab) Receives Suppl Approval in US
03 Oct 2024 //
FDA
Indoco`s Generics Cetirizine HCl Receives Approval in US
03 Oct 2024 //
FDA
Gland Pharma`s Generics Chlorothiazide Na Receives Approval in US
03 Oct 2024 //
FDA
Hetero Lab`s Generics Milnacipran HCl Receives Approval in US
03 Oct 2024 //
FDA
MSN`s Generics Nilotinib Receives Tentative Approval in US
02 Oct 2024 //
FDA
Alembic`s Generics Alcaftadine Receives Approval in US
02 Oct 2024 //
FDA
Jubilant`s Generics Solifenacin Receives Tentative Approval in US
02 Oct 2024 //
FDA
MSN`s Generics Nebivolol HCl Receives Approval in US
01 Oct 2024 //
FDA
Baxter`s Generics Eribulin mesylste Receives Approval in US
01 Oct 2024 //
FDA
Dr. Reddys`s Generics Varenicline Tartrate Receives Approval in US
01 Oct 2024 //
FDA
Alembic`s Generics Lamotrigine Receives Approval in US
01 Oct 2024 //
FDA
Fresenius Kabi`s Biologic Otulfi (Ustekinumab) Receives Approval in US
27 Sep 2024 //
FDA
Alembic`s Generics Paliperidone Receives Approval in US
26 Sep 2024 //
FDA
Synthon Pharma`s Generics Glatiramer Acetate Receives Approval in US
25 Sep 2024 //
FDA
Synthon`s Generics Glatiramer Acetate Receives Approval in US
25 Sep 2024 //
FDA
Krka`s Pomalidomide Receives Approval in Europe
24 Sep 2024 //
EMA
Baxter Hlthcare`s Generics Succinylcholine Cl Receives Approval in US
24 Sep 2024 //
FDA
Deva Holding`s Generics Chlorpromazine HCl Receives Approval in US
24 Sep 2024 //
FDA
Somerset`s Generics Dexmedetomidine HCl Receives Approval in US
24 Sep 2024 //
FDA
Kindos`s Generics Fluorouracil Receives Approval in US
24 Sep 2024 //
FDA
Cipla`s Generics Nicardipine HCl Receives Approval in US
24 Sep 2024 //
FDA
Somerset`s Generics Travoprost Receives Approval in US
23 Sep 2024 //
FDA
Eugia Pharma`s Generics Afatinib Receives Approval in US
23 Sep 2024 //
FDA
Annora Pharma`s Generics Fostamatinib Receives Approval in US
23 Sep 2024 //
FDA
UCB`s Biologic Bimzelx (Bimekizumab) Receives Suppl Approval in US
20 Sep 2024 //
FDA
Gland`s Generics Ephedrine Sulfate Receives Tentative Approval in US
20 Sep 2024 //
FDA
Sanofi `s Biologic Sarclisa (Isatuximad) Receives Suppl Approval in US
20 Sep 2024 //
FDA
Cipla`s Generics Calcitonin Salmon Receives Approval in US
20 Sep 2024 //
FDA
Cipla`s Generics Dihydroergotamine Mesylate Receives Approval in US
20 Sep 2024 //
FDA
MSN`s Generics Clopidogrel Bisulfate Receives Approval in US
20 Sep 2024 //
FDA
Macleods Pharma`s Generics Cevimeline HCl Receives Approval in US
20 Sep 2024 //
FDA
Janssen`s Biologic Rybrevant (Amivantamab) Receives Suppl Approval in US
19 Sep 2024 //
FDA
Alexion`s Biologic Ultomiris (Ravulizumab) Receives Suppl Approval in US
19 Sep 2024 //
FDA
Genentech`s Biologic Actemra(Tocilizumab) Receives Suppl Approval in US
19 Sep 2024 //
FDA
Qilu Pharma`s Generics Bumetanide Receives Approval in US
19 Sep 2024 //
FDA
Alexion`s Biologic Soliris (Eculizumab) Receives Suppl Approval in US
19 Sep 2024 //
FDA
Unique Pharma`s Generics Enalapril Maleate Receives Approval in US
19 Sep 2024 //
FDA
Biovitrum`s Biologic Kineret (Anakinra) Receives Suppl Approval in US
19 Sep 2024 //
FDA
Somerset`s Generics Nalbuphine HCl Receives Approval in US
19 Sep 2024 //
FDA
Prestige`s Tuznue (trastuzumab) Receives Approval in Europe
19 Sep 2024 //
EMA
Coherus`s Loqtorzi (toripalimab) Receives Approval in Europe
19 Sep 2024 //
EMA
Leo Pharma`s Anzupgo (delgocitinib) Receives Approval in Europe
19 Sep 2024 //
EMA
Astellas Pharma`s Vyloy (zolbetuximab) Receives Approval in Europe
19 Sep 2024 //
EMA
Ipsen Pharma`s Kayfanda (odevixibat) Receives Approval in Europe
19 Sep 2024 //
EMA
Ipsen Pharma`s Iqirvo (elafibranor) Receives Approval in Europe
19 Sep 2024 //
EMA
Appco`s Generics Bumetanide Receives Approval in US
18 Sep 2024 //
FDA
Travere`s Benralizumab Receives Approval in the U.S.
17 Sep 2024 //
FDA
AstraZeneca`s Biologic Fasenra (Benralizumab) Receives Approvals In U.S
17 Sep 2024 //
FDA
Genentech`s Biologic Ocrevus (Ocrelizumab) Receives Approval in US
13 Sep 2024 //
FDA
Genentech`s Biologic Zunovo (Hyaluronidase) Receives in US
13 Sep 2024 //
FDA
Alkem Lab`s Generics Ticagrelor Receives Tentative Approval in US
12 Sep 2024 //
FDA
BioMarin`s Biologic Naglazyme (Galsufase) Receives Approval in US
12 Sep 2024 //
FDA
Samsung Bioepis`s Eksunbi (ustekinumab) Receives Approval in Europe
12 Sep 2024 //
EMA
Janssen Biotech`s Biologic Tremfya (Guselkumab) Receives Approval in US
11 Sep 2024 //
FDA
Celltrion`s Steqeyma (ustekinumab) Receives Approval in Europe
11 Sep 2024 //
EMA
